Michael F. Gardner

1.8k total citations · 1 hit paper
37 papers, 1.3k citations indexed

About

Michael F. Gardner is a scholar working on Molecular Biology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael F. Gardner has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Epidemiology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael F. Gardner's work include Cytomegalovirus and herpesvirus research (8 papers), Receptor Mechanisms and Signaling (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Michael F. Gardner is often cited by papers focused on Cytomegalovirus and herpesvirus research (8 papers), Receptor Mechanisms and Signaling (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Michael F. Gardner collaborates with scholars based in United States, Canada and Netherlands. Michael F. Gardner's co-authors include Karl Y. Hostetler, Merryl Cramer, Joyce James, Patrick P. Zarrinkar, Shripad S. Bhagwat, Hitesh Patel, Qi Chao, Ruwanthi N. Gunawardane, Kelly G. Sprankle and Robert C. Armstrong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Michael F. Gardner

36 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)

2009 474 citations Patrick P. Zarrinkar, Merryl Cramer et al. profile →

Peers

Countries citing papers authored by Michael F. Gardner

Since Specialization

Citations

This map shows the geographic impact of Michael F. Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Gardner more than expected).

Fields of papers citing papers by Michael F. Gardner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Gardner. The network helps show where Michael F. Gardner may publish in the future.

Co-authorship network of co-authors of Michael F. Gardner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Gardner. A scholar is included among the top collaborators of Michael F. Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Gardner. Michael F. Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery and optimization of a highly efficacious class of 5-aryl-2-aminopyridines as FMS-like tyrosine kinase 3 (FLT3) inhibitors 2015 ·Bioorganic & Medicinal Chemistry Letters ·Gang Liu, Sunny Abraham, Xing Liu, Shimin Xu, (unknown), (unknown), (unknown), Daniel Brigham, (unknown), Darren E. Insko, Michael F. Gardner, Patrick P. Zarrinkar, (unknown), Barbara Belli, Robert C. Armstrong, Mark W. Holladay	16
2	Heterocycle-substituted proline dipeptides as potent VLA-4 antagonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Thomas S. Reger, (unknown), Nicholas Stock, Bowei Wang, Nicholas D. Smith, Benito Muñoz, Mitchell D. Green, Michael F. Gardner, Joyce James, Weichao Chen, (unknown), Qian Si, (unknown), Russell B. Lingham, Richard A. Mumford	7
3	Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3′,5′-dichloro-isonicotinoyl) amino]-(l)-phenylalanine (MK-0617), a highly potent and orally active VLA-4 antagonist 2009 ·Bioorganic & Medicinal Chemistry Letters ·Shankar Venkatraman, Alec D. Lebsack, (unknown), Michael F. Gardner, Joyce James, Russell B. Lingham, Salony Maniar, Richard A. Mumford, Qian Si, Nicholas Stock, (unknown), Bowei Wang, (unknown), Benito Muñoz	6
4	Influence of acid surrogates toward potency of VLA-4 antagonist 2005 ·Bioorganic & Medicinal Chemistry Letters ·Shankar Venkatraman, Jongwon Lim, Merryl Cramer, Michael F. Gardner, Joyce James, (unknown), Russell B. Lingham, Richard A. Mumford, Benito Muñoz	6
5	Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): Efficacy in an animal model for schizophrenia 2005 ·Bioorganic & Medicinal Chemistry Letters ·Steven P. Govek, Céline Bonnefous, John H. Hutchinson, Theodore M. Kamenecka, (unknown), Richard Pracitto, (unknown), Michael F. Gardner, Joyce K. James, Lorrie P. Daggett, Blake A. Rowe, Hervé Schaffhauser, Linda J. Bristow, Una C. Campbell, Dana E. Rodriguez, Jean‐Michel Vernier	35
6	Biphenyl-indanones: Allosteric potentiators of the metabotropic glutamate subtype 2 receptor 2005 ·Bioorganic & Medicinal Chemistry Letters ·Céline Bonnefous, Jean‐Michel Vernier, John H. Hutchinson, Michael F. Gardner, Merryl Cramer, Joyce K. James, Blake A. Rowe, Lorrie P. Daggett, Hervé Schaffhauser, Theodore M. Kamenecka	36
7	3-(2-Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy]butoxy}phenyl)propanoic acid: a brain penetrant allosteric potentiator at the metabotropic glutamate receptor 2 (mGluR2) 2005 ·Bioorganic & Medicinal Chemistry Letters ·Rowena V. Cube, Jean‐Michel Vernier, John H. Hutchinson, Michael F. Gardner, Joyce K. James, Blake A. Rowe, Hervé Schaffhauser, Lorrie P. Daggett, Anthony B. Pinkerton	18
8	Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-Thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators 2004 ·Bioorganic & Medicinal Chemistry Letters ·Anthony B. Pinkerton, Rowena V. Cube, John H. Hutchinson, Joyce K. James, Michael F. Gardner, Hervé Schaffhauser, Blake A. Rowe, Lorrie P. Daggett, Jean‐Michel Vernier	14
9	Ganciclovir Release Rates in Vitreous from Different Formulations of 1- O -Hexadecylpropanediol-3-Phospho-Ganciclovir 2003 ·Journal of Ocular Pharmacology and Therapeutics ·Lingyun Cheng, Karl Y. Hostetler, (unknown), James R. Beadle, (unknown), Michael F. Gardner, Kathy A. Aldern, (unknown), William R. Freeman	5
10	Discovery of novel modulators of metabotropic glutamate receptor subtype-5 2003 ·Bioorganic & Medicinal Chemistry ·Bowei Wang, Jean‐Michel Vernier, Sara Rao, Janice Chung, Jeffery J. Anderson, Jesse Brodkin, Xiaohui Jiang, Michael F. Gardner, Xiaoqing Yang, Benito Muñoz	24
11	In vivo pharmacological characterization of (±)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies 2003 ·Brain Research ·Tadimeti S. Rao, Richard T. Reid, Lucia Correa, Emily M. Santori, Michael F. Gardner, Aida Sacaan, Daniel S. Lorrain, Jean‐Michel Vernier	14
12	Synthesis and Antiviral Evaluation of 1-O-Hexadecylpropanediol-3-P-acyclovir: Efficacy Against HSV-1 Infection in Mice 2000 ·Nucleosides Nucleotides & Nucleic Acids ·James R. Beadle, Ganesh D. Kini, Kathy A. Aldern, Michael F. Gardner, (unknown), Rachel J. Rybak, Earl R. Kern, Karl Y. Hostetler	14
13	Intravitreal Toxicology and Therapeutic Efficacy of the Carboxymethyl Ester of the l- O -Octadecyl- sn -Glycerol-3-Phosphonoformate (ODG-PFA-O-Me), a Novel Lipid Antiviral Prodrug for Intraocular Drug Delivery 1999 ·Journal of Ocular Pharmacology and Therapeutics ·Lingyun Cheng, Karl Y. Hostetler, Michael F. Gardner, (unknown), (unknown), Kelly Keefe, James R. Beadle, Clayton A. Wiley, William R. Freeman	1
14	TREATMENT OF HERPES RETINITIS IN AN ANIMAL MODEL WITH A SUSTAINED DELIVERY ANTIVIRAL DRUG, LIPOSOMAL 1-O-OCTADECYL-SN-GLYCEROL-3-PHOSPHONOFORMATE 1999 ·Retina ·Lingyun Cheng, Karl Y. Hostetler, Sunan Chaidhawangul, Michael F. Gardner, Uğur Özerdem, (unknown), (unknown), Arthur Mueller, (unknown), William R. Freeman	5
15	Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug. 1999 ·PubMed ·Lingyun Cheng, Karl Y. Hostetler, Michael F. Gardner, (unknown), (unknown), Kelly Keefe, Clayton A. Wiley, W. R. Freeman	21
16	Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats 1996 ·Toxicology ·Mark J. Reasor, (unknown), (unknown), (unknown), Sam Kacew, Michael F. Gardner, Kathy A. Aldern, Karl Y. Hostetler	28
17	Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro 1996 ·Antiviral Research ·Karl Y. Hostetler, Ganesh D. Kini, James R. Beadle, Kathy A. Aldern, Michael F. Gardner, Richard Border, Raj Kumar, (unknown), Ch. Sridhar, Carl J. Wheeler, Douglas D. Richman	25
18	Phospholipid prodrug inhibitors of the HIV protease 1994 ·Biochemical Pharmacology ·Karl Y. Hostetler, Douglas D. Richman, Eric A. Forssen, Linda Selk, (unknown), Michael F. Gardner, Suezanne E. Parker, (unknown)	9
19	Antiviral activity of phosphatidyl-dideoxycytidine in hepatitis B-infected cells and enhanced hepatic uptake in mice 1994 ·Antiviral Research ·Karl Y. Hostetler, Brent E. Korba, Ch. Sridhar, Michael F. Gardner	20
20	[11] Assay of phospholipases C and D in presence of other lipid hydrolases 1991 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Karl Y. Hostetler, Michael F. Gardner, Kathy A. Aldern	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact